• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells 
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Molecular Oncology
    • Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Molecular Oncology
    • Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells

    View/Open
    Accepted version (8.979Mb)
    Volume
    23
    Pagination
    2880 - 2890
    DOI
    10.1158/1078-0432.CCR-16-1216
    Journal
    CLINICAL CANCER RESEARCH
    Issue
    11
    ISSN
    1078-0432
    Metadata
    Show full item record
    Authors
    Guillotin, D; Austin, P; Begum, R; Freitas, MO; Merve, A; Brend, T; Short, S; Marino, S; Martin, SA
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/19059
    Collections
    • Centre for Molecular Oncology [263]
    Copyright statements
    (c) The Author(s) 2016.
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.